H.R. 747 (119th)Bill Overview

Stop Chinese Fentanyl Act of 2025

International Affairs|AsiaChina
Sponsor
Cosponsors
Support
Republican
Introduced
Jan 28, 2025
Discussions
Bill Text
Current stageCommittee

Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The Stop Chinese Fentanyl Act of 2025 amends U.S. fentanyl sanctions law to explicitly include Chinese entities and senior Chinese officials as potential "foreign opioid traffickers" when they produce, distribute, finance, or fail to prevent synthetic opioids or precursors. It requires identification of specific Chinese agency heads for potential designation, extends certain designation durations, adds annual congressional evaluation and cost-benefit requirements when using IEEPA for covered drug-trafficking national emergencies, and bars imposing sanctions on the importation of goods.

Why people may split

Liberals stress pairing sanctions with domestic treatment investment

Watch point

Relative to its intended legislative type, this bill is a substantive policy change that builds on existing sanctions and emergency economic authorities by expanding statutory definitions to encompass certain Chinese entities and officials and by adding reporting and regulatory requirements intended to govern the exercise of those authorities.

The Stop Chinese Fentanyl Act of 2025 amends U.S. fentanyl sanctions law to explicitly include Chinese entities and senior Chinese officials as potential "foreign opioid traffickers" when they produce, distribute, finance, or fail to prevent synthetic opioids or precursors.

It requires identification of specific Chinese agency heads for potential designation, extends certain designation durations, adds annual congressional evaluation and cost-benefit requirements when using IEEPA for covered drug-trafficking national emergencies, and bars imposing sanctions on the importation of goods.

The bill also expresses congressional expectations that the Chinese government adopt know-your-customer rules, labeling, and stronger precursor controls.

Passage40/100

Content has bipartisan elements but high diplomatic sensitivity and Senate procedural hurdles reduce probability absent negotiation or compromise.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive policy change that builds on existing sanctions and emergency economic authorities by expanding statutory definitions to encompass certain Chinese entities and officials and by adding reporting and regulatory requirements intended to govern the exercise of those authorities.

Contention55/100

Liberals stress pairing sanctions with domestic treatment investment

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitEnables targeted sanctions on Chinese producers, distributors, and culpable officials involved in fentanyl supply chain…
  • Potential benefitCreates a stronger legal basis to pressure China to implement precursor controls and improved shipment labeling.
  • Potential benefitAdds annual oversight and required cost‑benefit analysis for IEEPA actions during covered drug trafficking emergencies.
Likely burdened
  • Potential burdenMay escalate diplomatic tensions with China and invite reciprocal measures affecting broader relations.
  • Potential burdenCould prompt increased compliance costs for multinational chemical firms and financial institutions performing enhanced…
  • Potential burdenDesignation of foreign officials raises potential legal and diplomatic due process and sovereign immunity concerns.
03 · Why people split

Why the argument around this bill splits.

Liberals stress pairing sanctions with domestic treatment investment
Progressive70%

Generally supportive of measures to disrupt overseas sources of fentanyl, but cautious about overreliance on sanctions instead of public-health responses.

Likely to welcome accountability for foreign producers while urging complementary investments in treatment, harm reduction, and demand reduction domestically.

Concerned about potential diplomatic escalation and civil liberties implications if evidence standards are unclear.

Leans supportive
Centrist75%

Favorable overall: sees targeted sanctions and stronger oversight as reasonable tools to disrupt fentanyl supply while protecting trade.

Appreciates the bill's reporting, cost-benefit requirements, and the exception for imports.

Wants assurance about feasibility, legal standards, and coordination with allies.

Leans supportive
Conservative90%

Strongly supportive of robust measures to pressure China and punish entities and officials facilitating fentanyl trafficking.

Views expanded designation authority as necessary leverage.

May prefer even tougher trade or financial measures but welcomes explicit targeting and accountability provisions.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Content has bipartisan elements but high diplomatic sensitivity and Senate procedural hurdles reduce probability absent negotiation or compromise.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • Administration willingness to pursue or accept designations
  • Potential diplomatic retaliation from China
05 · Recent votes

Recent votes on the bill.

HOUSE · Sep 2, 2025
Fast-track passage✓ PassedBipartisanNear-unanimous
2/3 majority required

The House fast-tracked this bill — skipping normal debate — and it passed with a two-thirds majority. It now moves to the Senate.

What is a fast-track passage?

Suspending the rules allows the House to bypass normal debate procedures and pass a bill immediately with a two-thirds vote.

Yes 99% No 1%
Showing a quick cross-section of legislators, with followed members first when available.
06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals stress pairing sanctions with domestic treatment investment

Content has bipartisan elements but high diplomatic sensitivity and Senate procedural hurdles reduce probability absent negotiation or comp…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive policy change that builds on existing sanctions and emergency economic authorities by expanding statutory definitions to encompass certain Chinese en…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis